Navigation Links
HemoShear Hires Industry Business Development Veteran Vincent Aurentz as Chief Business Officer
Date:8/6/2013

CHARLOTTESVILLE, Va., Aug. 6, 2013 /PRNewswire/ -- HemoShear, LLC, a leading developer of human-relevant systems for drug discovery and development, today announced that Vincent Aurentz has joined HemoShear as the Company's Chief Business Officer.  Mr. Aurentz is widely respected in the pharmaceutical industry and brings to HemoShear a very strong combination of executive management experience in pharmaceutical R&D, licensing and business development, as well as expertise in building strategic partnerships.  

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

Mr. Aurentz has worked for over 24 years in life sciences.  Most recently, he was Executive Vice President of the Customer Solutions Business at Quintiles where he created a new business model to engage their customers.  Previously, he spent almost nine years with Merck KGaA where he served as Executive Vice President, Portfolio Development, for Merck Serono and was a member of the Executive Management Board.   He was responsible for Licensing and Business Development, Global Product leadership for the R&D pipeline, and Portfolio Management.  Prior to his role at Merck Serono, he was Merck KGaA's Global Head of Licensing and Business Development.  Mr. Aurentz is formerly a co-founder and Managing Director of True North Partners, a venture capital and advisory business focused on the healthcare industry. He was also a partner for CSC Healthcare in New York and worked at Andersen Consulting (now known as Accenture).

"I am excited to join HemoShear's talented organization," said Mr. Aurentz.  "I was struck by the quality of the science that HemoShear has developed, its potential to improve the productivity of drug R&D, and their vision for broad partnerships with pharma.  In considering the opportunity to join HemoShear, I spoke with several executives in pharma who shared a consistent message regarding the value of HemoShear's science in understanding human biology and response to new drug candidates at a level that has not existed before."

"Vince is an outstanding addition to HemoShear's executive team.  As we grow, we want to recruit the best people in the industry to drive our business," said James Powers, HemoShear's CEO.  "Vince's expertise will help us unlock the immense value that our enabling science brings to our pharmaceutical partners' drug R&D programs."

About HemoShear, LLC

By applying physiologically accurate hemodynamics and biological transport to primary cell cultures, HemoShear creates human-relevant systems that accurately replicate the biology of organ systems and diseases for applications throughout drug discovery and development. Working in strategic partnerships with pharmaceutical, biotechnology and medical device companies, HemoShear generates meaningful data to increase confidence in decision-making, reduce risk of costly failures and identify efficacious therapies. HemoShear's science leads to new medicines and improves human health.  

For information about HemoShear, please visit www.hemoshear.com.

 


'/>"/>
SOURCE HemoShear, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. HemoShear to Present at Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Conference
2. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
3. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
4. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
5. Textile Company PurThread Technologies Opens Headquarters in Durham, North Carolina and Hires New Senior Staff
6. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
7. Ernst & Young LLP Bolsters Fraud Investigation & Dispute Services with New Hires and Promotions
8. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
9. Ganeden Biotech Hires New Marketing Manager
10. PathoGenetix Hires Food Safety Testing Expert John W. Czajka as Vice President of Business Development
11. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... , ... AMRI, a global contract research, development and manufacturing ... and quality of life, will now be offering its impurity solutions as a ... requirements for all new drug products, including the finalization of ICH M7 earlier ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
Breaking Biology Technology:
(Date:6/30/2017)... 30, 2017 Today, American Trucking Associations ... of face and eye tracking software, became the ... program. "Artificial intelligence and advanced ... monitor a driver,s attentiveness levels while on the ... to detect fatigue and prevent potential accidents, which ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
Breaking Biology News(10 mins):